Fingerprint
Dive into the research topics of 'RC0639: Phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
RC0639: Phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
Alvaro Moreno-Aspitia, Amylou C. Dueck, Ismael Ghanem-Cañete, Tejal Patel, Shaker Dakhil, David Johnson, Sandra Franco, Stephen Kahanic, Gerardo Colon-Otero, Kathleen S. Tenner, Richard Rodeheffer, Ann E. McCullough, Robert B. Jenkins, Frances M. Palmieri, Donald Northfelt, Edith A. Perez
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations